The Middle East insulin pump market is projected to grow from USD 390 billion in 2025 to USD 940.35 billion by 2035, expanding at a CAGR of 9.20%, driven by rising diabetes prevalence, technological advancements, and increasing healthcare investments.

Middle East Insulin Pump Market Statical Scope

The market is mainly fueled by the fast-growing number of diabetes cases, particularly in the GCC area, along with a rise in lifestyle-related non-communicable diseases.

This market is vital due to the alarmingly high and increasing rates of diabetes, with Saudi Arabia and Kuwait having some of the highest figures globally. The combination of high disposable incomes and the quick uptake of advanced healthcare technologies, like smart and patch pumps, is expected to drive market growth, making it a region of high demand and investment for global medical technology companies. Growing awareness, along with significant healthcare spending and government initiatives aimed at improving diabetes care, promotes the use of advanced and user-friendly devices. Increased government attention on diabetes management in the GCC has resulted in better insurance coverage for modern devices, enhancing market accessibility.

Middle East Insulin Pump Market Share, By Type, 2025 (%)

• Patch Pumps - Patch pumps account for a notable 42% share, fueled by the increasing demand for discreet, wearable, and user-friendly insulin delivery systems that improve patient convenience and mobility.
• Tethered Pumps - Tethered pumps lead the market with a 58% share, due to their proven clinical reliability, accurate insulin delivery control, and widespread use in long-term diabetes care.

Middle East Insulin Pump Market Share, By Product, 2025 (%)

• MiniMed - MiniMed is the market leader with a 24% share, driven by strong brand loyalty, cutting-edge insulin delivery technology, and broad clinical acceptance among various patient demographics.
• Accu-Chek - Accu-Chek maintains a consistent 18% share, supported by its robust global presence and compatibility with glucose monitoring systems.

Middle East Insulin Pump Market Share, By Accessories, 2025 (%)

• Insulin Reservoir/Cartridges - Insulin reservoir/cartridges command a 45% share of the market, propelled by their regular replacement needs and crucial function in continuous insulin delivery.
• Insulin Set Insertion Devices - Insulin set insertion devices represent a significant 35% share, underpinned by their vital role in ensuring safe and effective pump operation.

Middle East Insulin Pump Market Share, By End Use, 2025 (%)

• Hospitals & Clinics - Hospitals and clinics dominate the sector with a 52% share, driven by a high volume of patients seeking diabetes management, monitoring, and clinical oversight.
• Homecare - The homecare segment, with a share of 42%, is vital in the market, driven by the increasing need for convenient, independent diabetes management, reduced hospital visits, the rise of telemedicine, and the growth of remote patient monitoring.

Top Companies in the Middle East Insulin Pump Market

• Medtronic
• Hoffmann-La Roche AG
• Tandem Diabetes Care, Inc.
• Insulet Corporation
• Ypsomed
• Sanofi S.A.
• Sooil development
• Jiangsu Delfu Co., Ltd.
• Cellnovo Ltd
• Valeritas, Inc

Segments Covered in the Report

By Type

• Patch pumps
• Tethered pumps

By Product

• MiniMed
• Accu-Chek
• Tandem
• Omnipod
• My life omnipod
• Others

By Accessories

• Insulin reservoir or cartridges
• Insulin set insertion devices
• Battery

By End User

• Hospitals & clinics
• Homecare
• Laboratories